Business Description
JRSIS Health Care Corp
NAICS : 622110
SIC : 8361
ISIN : US4662801046
Description
JRSIS Health Care Corp is engaged in operating Jiarun Hospital, a private hospital with nearly 950 open beds. The Jiarun Hospital services in the areas of pediatrics, dermatology, ears, nose, and throat (ent), traditional Chinese medicine (TCM), ophthalmology, internal medicine dentistry, general surgery, rehabilitation science, gynecology, general medical services, and others. It also offers patient care and the sale of medicine in the areas of both Western and Chinese medical practices to the residents of Harbin.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | -0.12 | |||||
Debt-to-Equity | -5.58 | |||||
Debt-to-EBITDA | -725.5 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.96 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -94.1 | |||||
3-Year FCF Growth Rate | -90.8 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.88 | |||||
9-Day RSI | 87.3 | |||||
14-Day RSI | 55.73 | |||||
6-1 Month Momentum % | -54.31 | |||||
12-1 Month Momentum % | -46.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.76 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 371.18 | |||||
Days Sales Outstanding | 40.9 | |||||
Days Payable | 230.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -256.4 | |||||
Shareholder Yield % | -0.63 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.82 | |||||
Operating Margin % | -5.83 | |||||
Net Margin % | -2.7 | |||||
FCF Margin % | 8.28 | |||||
ROE % | -39.31 | |||||
ROA % | -8.62 | |||||
ROIC % | -23.53 | |||||
ROC (Joel Greenblatt) % | -13.79 | |||||
ROCE % | -25.49 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.12 | |||||
Price-to-Free-Cash-Flow | 69 | |||||
Price-to-Operating-Cash-Flow | 69 | |||||
EV-to-EBIT | -543.21 | |||||
EV-to-EBITDA | -18469 | |||||
EV-to-Revenue | 9.32 | |||||
EV-to-FCF | 112.62 | |||||
Price-to-Projected-FCF | 13.8 | |||||
Earnings Yield (Greenblatt) % | -0.18 | |||||
FCF Yield % | 0.94 | |||||
Forward Rate of Return (Yacktman) % | 312.91 |